Literature DB >> 12851711

Cloning and characterization of a novel splicing isoform of USF1.

Tomoko Saito1, Takayuki Oishi, Kazuyuki Yanai, Yoko Shimamoto, Akiyoshi Fukamizu.   

Abstract

The ubiquitous basic helix-loop-helix transcription factor USFs encoded by two distinct genes (USF1 and USF2) recognize a core motif, CACGTG, termed E box and regulate the expression of a variety of genes. USF1 and USF2 proteins form homo- and heterodimers to bind the target core motif DNA. Here, we report the molecular cloning and functional characterization of a novel alternative splicing variant of human USF1 (hUSF1), termed USF1/BD. Compared with USF1 wild-type (wt), USF1/BD lacks the N-terminal transactivation domain. Cloning and characterization of the hUSF1 genomic region revealed that USF1/BD is generated by excising the sequence corresponding to a part of exon 4. In transiently transfected cells, USF1/BD was localized in the nucleus and repressed the promoter activity of the human angiotensinogen gene. In vitro translated USF1/BD possessed DNA binding activity as a homodimer and a heterodimer with USF1 (wt). These results suggest that USF1/BD plays a role as a modulator of USF1 to control the expression of target genes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12851711

Source DB:  PubMed          Journal:  Int J Mol Med        ISSN: 1107-3756            Impact factor:   4.101


  3 in total

1.  Upstream stimulatory factor is required for human angiotensinogen expression and differential regulation by the A-20C polymorphism.

Authors:  Matthew E Dickson; Xin Tian; Xuebo Liu; Deborah R Davis; Curt D Sigmund
Journal:  Circ Res       Date:  2008-09-18       Impact factor: 17.367

2.  Allele-specific expression of angiotensinogen in human subcutaneous adipose tissue.

Authors:  Sungmi Park; Ko-Ting Lu; Xuebo Liu; Tapan K Chatterjee; Steven M Rudich; Neal L Weintraub; Anne E Kwitek; Curt D Sigmund
Journal:  Hypertension       Date:  2013-05-06       Impact factor: 10.190

3.  Protein kinases as switches for the function of upstream stimulatory factors: implications for tissue injury and cancer.

Authors:  Tina Horbach; Claudia Götz; Thomas Kietzmann; Elitsa Y Dimova
Journal:  Front Pharmacol       Date:  2015-02-18       Impact factor: 5.810

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.